The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant ...

With historical data showing migraine to be underdiagnosed and undertreated, new guidance from the American College of ...

The Clinical Guidelines Committee of the American College of Physicians (ACP) has released a new clinical guideline on the ...

The ACP issued new clinical guidance on preventing episodic migraines, classified as one to 14 headache days per month, in ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

In this systematic review, patients with episodic migraine preferred oral pharmacologic treatments that reduced the severity, ...

Migraines affect millions worldwide, yet remain widely misunderstood. This neurological condition extends far beyond typical headache symptoms, often ...

Vestibular migraines are more likely to affect ... t a medication specifically for treating vestibular migraine. Your treatment may include medications to prevent attacks or stop symptoms once ...

For Roshelle, her diagnosis of migraine disease became the catalyst for a life of advocacy, empowerment, and community ...

A common drug used to prevent migraines might have an additional benefit -- protecting women against stroke. Women taking the ...

"Patients diagnosed with headache may benefit from concurrent behavioral health evaluation and treatment," researchers said.

The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant adults in outpatient settings.